Evonik partners with ST Pharm to increase its offerings for RNA and nucleic acid delivery
Evonik increases speed to market for drug developers working on nucleic acid therapeutics ... MORE
PRESS RELEASES
Find the latest news from our company.
Evonik to restructure its keto and pharma amino acid business
Evonik is transforming its Health Care business to focus on its strategic core growth areas. ... MORE
Evonik wins CPHI Pharma Award for its plant-based squalene PhytoSquene®
Evonik has won this year’s CPHI Pharma Award in the category “Sustainability”. The winning innovation is the plant-based squalene, PhytoSquene®, which can be used for parenteral drug delivery applications, and is the first plant-based squalene in GMP quality. ... MORE
Evonik establishes Global Competence Network for Cell Culture Solutions
The Global Competence Network brings together a multidisciplinary team of business, application technology and research and development experts in chemistry, cell biology, bioprocessing and media optimization across Asia, Europe and the Americas. ... MORE
Evonik launches EUDRACAP® colon functional capsules for the targeted delivery of oral drugs
Evonik is expanding its EUDRACAP® portfolio with a new functional, ready-to-fill capsule that enables the delivery of sensitive active ingredients to the ileo-colonic region. ... MORE
Evonik starts operation of new spray drying facility for pharmaceutical oral excipients
The new double-digit million-euro facility for drying aqueous dispersions of EUDRAGIT® polymers at the company's site in Darmstadt enables Evonik to meet the increasing demand from pharmaceutical customers for oral drug delivery solutions. ... MORE
More releases
-
Sep 10, 2024Health Care
-
Aug 13, 2024Evonik expands its formulation capabilities for lipid nanoparticles used for mRNA and gene therapiesHealth Care
-
Jul 01, 2024Personnel News
-
May 14, 2024Health Care
-
Mar 21, 2024Health Care
-
Mar 14, 2024Health Care
-
Feb 20, 2024Health Care
-
Oct 23, 2023Health Care
-
Oct 18, 2023Health Care